<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Subst Use Addctn J</journal-id><journal-id journal-id-type="iso-abbrev">Subst Use Addctn J</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Substance use &amp; addiction journal</journal-title></journal-title-group><issn pub-type="ppub">2976-7342</issn><issn pub-type="epub">2976-7350</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11179974</article-id><article-id pub-id-type="pmcid-ver">PMC11179974.319</article-id><article-id pub-id-type="pmcaid">11179974</article-id><article-id pub-id-type="pmcaiid">11179974</article-id><article-id pub-id-type="manuscript-id">NIHMS1980549</article-id><article-id pub-id-type="pmid">38494728</article-id><article-id pub-id-type="doi">10.1177/29767342241236028</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1980549</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1980549</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4178-0720</contrib-id><name name-style="western"><surname>Tilhou</surname><given-names initials="AS">Alyssa Shell</given-names></name><degrees>MD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Burns</surname><given-names initials="M">Marguerite</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chachlani</surname><given-names initials="P">Preeti</given-names></name><degrees>MA</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Y">Ying</given-names></name><degrees>MA</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dague</surname><given-names initials="L">Laura</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Family Medicine, Boston University Medical Center, Boston, MA, USA</aff><aff id="A2"><label>2</label>Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA</aff><aff id="A3"><label>3</label>Institute for Research on Poverty, University of Wisconsin-Madison, Madison, WI, USA</aff><aff id="A4"><label>4</label>Department of Risk and Insurance, Wisconsin School of Business, University of Wisconsin-Madison, Madison, WI, USA</aff><aff id="A5"><label>5</label>The Bush School of Government and Public Service, Texas A&amp;M University, College Station, TX, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author Contributions</p><p id="P2">AST and MB originated the project. MB and LD obtained funding. AST, MB and LD drafted the initial manuscript. MB and LD secured the data. All authors participated in conducting the analyses and interpreting the results. AST led the writing. All authors participated in editing and providing critical feedback to the manuscript. All authors approved the final manuscript draft for submission.</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Alyssa Shell Tilhou, Department of Family Medicine, Boston University Medical Center, 771 Albany Street, Dowling 5507A, Boston, MA 02118, USA. <email>alyssa.tilhou@bmc.org</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P39">Declaration of Conflicting Interests</p><p id="P40">The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn></author-notes><pub-date pub-type="ppub"><month>7</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>3</month><year>2024</year></pub-date><volume>45</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">464954</issue-id><fpage>473</fpage><lpage>485</lpage><pub-history><event event-type="nihms-submitted"><date><day>07</day><month>04</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-01 00:25:30.177"><day>01</day><month>07</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1980549.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P3">Patients with substance use disorders (SUDs) exhibit low healthcare utilization despite high medical need. Telehealth could boost utilization, but variation in uptake across SUDs is unknown.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">Using Wisconsin Medicaid enrollment and claims data from December 1, 2018, to December 31, 2020, we conducted a cohort study of telemedicine uptake in the all-ambulatory and the primary care setting during telehealth expansion following the COVID-19 public health emergency (PHE) onset (March 14, 2020). The sample included continuously enrolled (19 months), nonpregnant, nondisabled adults aged 19 to 64 years with opioid (OUD), alcohol (AUD), stimulant (StimUD), or cannabis (CannUD) use disorder or polysubstance use (PSU). Outcomes: total and telehealth visits in the week, and fraction of visits in the week completed by telehealth. Linear and fractional regression estimated changes in in-person and telemedicine utilization. We used regression coefficients to calculate the change in telemedicine utilization, the proportion of in-person decline offset by telemedicine uptake (&#8220;offset&#8221;), and the share of visits completed by telemedicine (&#8220;share&#8221;).</p></sec><sec id="S3"><title>Results:</title><p id="P5">The cohort (n = 16 756) included individuals with OUD (34.8%), AUD (30.1%), StimUD (9.5%), CannUD (9.5%), and PSU (19.7%). Total and telemedicine utilization varied by group post-PHE. All-ambulatory: total visits dropped for all, then rose above baseline for OUD, PSU, and AUD. Telehealth expansion was associated with visit increases: OUD: 0.489, <italic toggle="yes">P</italic> &lt; .001; PSU: 0.341, <italic toggle="yes">P</italic> &lt; .001; StimUD: 0.160, <italic toggle="yes">P</italic> &lt; .001; AUD: 0.132, <italic toggle="yes">P</italic> &lt; .001; CannUD: 0.115, <italic toggle="yes">P</italic> &lt; .001. StimUD exhibited the greatest telemedicine share. Primary care: total visits dropped for all, then recovered for OUD and CannUD. Telemedicine visits rose most for PSU: 0.021, <italic toggle="yes">P</italic> &lt; .001; OUD: 0.019, <italic toggle="yes">P</italic> &lt; .001; CannUD: 0.011, <italic toggle="yes">P</italic> &lt; .001; AUD: 0.010, <italic toggle="yes">P</italic> &lt; .001; StimUD: 0.009, <italic toggle="yes">P</italic> &lt; .001. PSU and OUD exhibited the greatest telemedicine share, while StimUD exhibited the lowest. Telemedicine fully offset declines for OUD only.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P6">Telehealth expansion helped maintain utilization for OUD and PSU; StimUD and CannUD showed less responsiveness. Telehealth expansion could widen gaps in utilization by SUD type.</p></sec></abstract><kwd-group><kwd>telehealth</kwd><kwd>stimulant use disorder</kwd><kwd>alcohol use disorder</kwd><kwd>cannabis use disorder</kwd><kwd>opioid use disorder</kwd><kwd>polysubstance use</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>